Urology Doctors in Denton, TX Accepting Medicare

4 Urology doctors found. Showing 1 - 4

Dr. Jonathan Henry Demeter, MD Urology Medicare: Medicare Enrolled Practice Location: 3537 S Interstate 35 E Ste 315, Denton, TX 76210 Phone: 940-536-0706

Dr. Thomas Joseph Thomas, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 3537 S Interstate 35 E, Suite 320, Denton, TX 76210 Phone: 940-383-1581    Fax: 940-383-4627

Dr. Galen Evan Howard, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3537 S Interstate 35 E Ste 315, Denton, TX 76210 Phone: 940-365-0706    Fax: 940-536-0710

John W Jaderlund, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 2401 W Oak St Ste 102, Denton, TX 76201 Phone: 940-387-2241    Fax: 940-380-1374

News Archive

Examining potential implications of the Affordable Care Act on global health

In this post in the Global Health Governance Blog, contributing blogger David Fidler, a professor of law at Indiana University's Maurer School of Law, examines the potential implications of the Affordable Care Act (ACA) on global health law, writing, "In the midst of this constitutional and political moment, I find myself wondering what this seminal American case means, if anything, beyond the United States in the realm of global health."

IDEA clinical study seeks to promote weight loss among young adults

Obesity It's a national epidemic and on the rise in young adults. Using technology to combat this problem, the University of Pittsburgh Physical Activity and Weight Management Research Center will offer the IDEA (Innovative Approaches to Diet, Exercise, and Activity) study, one of seven clinical trials to be funded by the National Institutes of Health's (NIH) National Heart, Lung, and Blood Institute.

High BMI linked to cognitive decline through systemic inflammation, research shows

There are plenty of reasons it's important to maintain a healthy weight, and now you can add one more to the list: It may be good for your brain.

Champions enters exclusive license agreement with BCCA for Irinophore C

Champions Biotechnology, Inc. announced today that it has exercised an option to license Irinophore C, a liposomal formulation of Irinotecan, from the BC Cancer Agency in British Columbia, Canada.

New opportunity for developing simple test to measure E2F4 activity in ER+ breast cancer patients

By looking at the expression levels of downstream genes of the regulators in breast cancer, investigators at Dartmouth Hitchcock's Norris Cotton Cancer Center, led by Chao Cheng, PhD, have identified a gene signature in E2F4 that is predictive of estrogen receptor positive (ER+) breast cancer.

Read more Medical News

› Verified 4 days ago